In Brief: Vistakon
This article was originally published in The Gray Sheet
Executive Summary
Vistakon: Johnson & Johnson Vision Care Division names James Callahan as the company's new president. Callahan replaces Gary Kunkle, who resigned as president to fill another position. Callahan previously served as president of Ciba Pharmaceuticals. He was slated for the post of president of Novartis Pharmaceuticals, the U.S. company being formed by the merger of Ciba and Sandoz...